Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2Phase EARLY_PHASE1 1Phase 1 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

NETWORK 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2

Conditions

Carcinoma, Non-Small-Cell Lung 62Breast Neoplasms 44Prostatic Neoplasms 35Lung Neoplasms 29Multiple Myeloma 24Neoplasms 22Colorectal Neoplasms 19Parkinson Disease 4, Autosomal Dominant Lewy Body 18Ovarian Neoplasms 17Neoplasm Metastasis 17Leukemia, Lymphocytic, Chronic, B-Cell 17Carcinoma, Renal Cell 15Pancreatic Neoplasms 13Small Cell Lung Carcinoma 12Endometrial Neoplasms 12Urinary Bladder Neoplasms 10Stomach Neoplasms 10Squamous Cell Carcinoma of Head and Neck 10Leukemia, Myeloid, Acute 10Myasthenia Gravis 9Lymphoma, Follicular 9Fallopian Tube Neoplasms 9Non-Muscle Invasive Bladder Neoplasms 8Colonic Neoplasms 8Recurrence 7Burkitt Lymphoma 7Lymphoma, Mantle-Cell 6Esophageal Neoplasms 6Carcinoma 6Biliary Tract Neoplasms 6

Interventions

Surgical Procedures, Operative 1PM 01183 1Neoadjuvant Therapy 1Doxorubicin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Leiomyosarcoma × 30 days × Clear all
NCT04031677 2026-05-22

STRASS2

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Recruiting
250 enrolled
Sarcoma

Leiomyosarcoma, Liposarcoma

NCT06088290 2026-05-15

SaLuDo

PharmaMar

Phase 3 Active not recruiting
455 enrolled
Sarcoma

Leiomyosarcoma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡